Life sciences news
-
Jyseleca® (filgotinib) approved by European Commission for rheumatoid arthritis
Friday September 25th 2020
Read more
-
Jyseleca® (filgotinib) approved in Japan for rheumatoid arthritis
Friday September 25th 2020
Read more
-
Mithra announces commercial launch of Tibelia® in Canada
Thursday July 30th 2020
Read more
-
US multicenter study shows Idylla™ allows rapid and accurate mutation testing results across different laboratory settings
Friday June 26th 2020
Read more
-
Mithra signs LSA for commercialization of Tibelia® in Liechtenstein and Switzerland
Thursday June 11th 2020
Read more
-
Johnson & Johnson announces acceleration of its COVID-19 vaccine candidate
Thursday June 11th 2020
Read more
-
icometrix lanceert icompanion-platform voor mensen met multiple sclerose
Tuesday June 2nd 2020
Read more
-
argenx announces positive topline results from Phase 3 ADAPT Trial of Efgartigimod in patients with Generalized Myasthenia Gravis
Tuesday May 26th 2020
Read more
-
Become a flanders.bio member
Your news here?
-
Gilead and Galapagos announce positive topline results of Phase 2B/3 trial of Filgotinib
Thursday May 21st 2020
Read more
-
Mithra and Searchlight Pharma announce filing of new drug submission for Estelle® in Canada
Wednesday May 20th 2020
Read more
-
Progressing clinical development of next generation therapies for Diabetic eye disease – beyond anti-VEGF
Friday May 8th 2020
Read more
More info?
Contact us
Ellen Telleir
Communication Coordinator
